News | Cath Lab | July 27, 2016

Excluding High-Risk Patients from Public Reporting Linked to Improved PCI Outcomes

New findings show increased willingness among doctors to perform high-risk procedures when outcomes reporting policies change

PCI outcomes, public reporting, high-risk patients, JAMA Cardiology, Beth Israel Deaconess Medical Center study

July 27, 2016 — A number of states mandate public reporting of mortality outcomes following certain cardiac procedures. While such reporting was originally intended to increase transparency and improve quality of care, a new study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) and the University of Washington has shown that public reporting may in fact disincentivize physicians from offering potentially lifesaving treatment to patients who are at the greatest risk of mortality and poor outcomes. However, reforms to public reporting policies can mitigate these undesired effects, the authors report in a paper published online in JAMA Cardiology.

The researchers analyzed the hospital discharge records of more than 45,000 cardiac patients who suffered a severe heart attack complicated by life-threatening cardiogenic shock. The researchers found that physicians were much more likely to perform percutaneous coronary intervention (PCI) — a procedure used to treat narrowed coronary arteries — after this subset of high-risk patients was excluded from public reporting criteria. More important, the researchers also saw a significant decrease in mortality among these critically-ill patients, suggesting that certain reporting policies may discourage physicians from performing risky procedures even when patients could benefit from it.

“The drop in mortality we observed suggests that changing the policy to exclude the sickest patients changed physician behavior and may have also improved public health,” explained corresponding author Robert Yeh, M.D., MSc, an interventional cardiologist, director of the Smith Center for Outcomes Research in Cardiology at BIDMC and associate professor of medicine at Harvard Medical School. “Our previous work found that elderly patients or those presenting with shock or cardiac arrest were even less likely to undergo a potentially lifesaving procedure in states with public reporting.”

In 1992, New York was the first state to publicly report mortality outcomes following PCI. In 2006, on the basis of concern that physicians were not treating patients in order to avoid risk, the New York Department of Public Health changed this policy and began excluding patients with cardiogenic shock from the publicly reported PCI risk-adjusted mortality analyses.

“This change in policy in New York provided us with a unique opportunity to study the effects of excluding certain patients from public reporting on physician behavior,” explained James McCabe, M.D., medical director of the cardiac catheterization laboratories at the University of Washington, who co-led the study with Yeh. “We were able to design a study that compared treatment strategies and outcomes before and after the policy change in New York, and simultaneously compare these to what was happening in other states that did not change their policies.”

Using several comprehensive hospitalization databases, the authors identified all patients with acute myocardial infarction and shock from Jan. 1, 2002 through Dec. 31, 2011 in several states. They compared New York data — before and after the reporting requirement changes made in 2006 — with data from Massachusetts, Michigan, New Jersey and California. Massachusetts is a public reporting state; the other three states are not.

They found that after the policy change in New York in 2006, cardiologists were 28 percent more likely to perform high-risk PCI, a significantly greater change than the 9 percent increase seen in comparator states. Simultaneously, the in-hospital mortality rates among patients with heart attacks complicated by shock declined by 24 percent after 2006, compared to only 9 percent in the other states.

“There is great enthusiasm for expanding public reporting of procedural outcomes, but the manner in which these policies are implemented can determine whether they ultimately prove beneficial or harmful to patient health,” said Yeh. “We hope this study can help shape future policies aimed at improving both transparency and outcomes for cardiac procedures.”

In addition to Yeh and McCabe, study coauthors include Steven W. Waldo, M.D., Veterans Affairs Eastern Colorado Health Care System; and Kevin F. Kennedy, MS, of St. Luke’s/Mid America Heart Institute.

Funding for this project was provided by Massachusetts General Hospital’s Hassenfeld Scholar Award and from the Richard A. and Susan F. Smith Center for Outcomes Research at BIDMC.

For more information: www.cardiology.jamanetwork.com

Related Content

Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
360 Photos | Cath Lab | April 20, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
SCAI Announces Global Lecture Series for 2018 Scientific Sessions
News | Cath Lab | April 18, 2018
Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego,...
Overlay Init